drugset / Trial / NCT00002452

A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

NCT00002452 ↗

Phase 2 Completed 30 enrolled Merck Sharp & Dohme LLC
Treatment

Summary

The purpose of this study is to see if L-756423, an anti-HIV drug, is safe to give with indinavir and if it works well at lowering the level of HIV in the blood (viral load).

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject L-756423 Small molecule 800 mg —
Background INDINAVIR ANHYDROUS Other / unclassified 400 mg —